<unk>  (INNs) is a fixed dose combination drug for the treatment of HIV infection. It combines<unk>  (not available as a single drug) with a sub-therapeutic dose of<unk>  (trade name Norvir) into a fixed-dose pill.
The combination is marketed by Abbott as Kaletra (high-income countries) and Aluvia (low-income countries), as a component of combination therapy to treat HIV/AIDS. The Kaletra formulation has also been used successfully as monotherapy in some studies.
As of 2006,<unk>  forms part of the preferred combination for first-line therapy recommended by the United States Department of Health and Human Services (DHHS). It is available as capsules, tablets and oral solution.
Lopinavir ritonavir
Saquinavir mesylate
Fosamprenavir
Dolutegravir / rilpivirine
Sofosbuvir / velpatasvir
Nelfinavir
Elbasvir / grazoprevir
Ledipasvir / sofosbuvir